Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Some of the concerns and predictions HIV/AIDS advocates made two years ago about the impact of Medicare Part D—the prescription drug benefit—on HIV antiretroviral treatment appear to be coming true.

Medicare Part D has big impact on HIV treatment interruptions